Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. II. 6-(3-(1-Cyclohexyl-5-tetrazolyl)propoxy)-1,2-dihydro-2-oxoquinoline and related compounds.
- 1 January 1983
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 31 (4) , 1151-1157
- https://doi.org/10.1248/cpb.31.1151
Abstract
A series of .omega.-(1-substituted-5-tetrazolylalkoxy)-2-oxoquinolines was synthesized and tested for inhibitory activity towards collagen- and ADP-induced aggregation of rabbit blood platelets in vitro. These compounds were prepared by the reaction of 1-substituted-5-(.omega.-chloroalkyl)-tetrazoles and hydroxy-2-oxoquinolines in the presence of a base. Among them, 6-[3-(1-cyclohexyl-5-tetrazolyl)propoxyl]-1,2-dihydro-2-oxoquinoline (IVb) had the most potent inhibitory activity. The structure-activity relationships are discussed.This publication has 1 reference indexed in Scilit:
- THE SYNTHESIS OF 1,5-DISUBSTITUTED TETRAZOLESThe Journal of Organic Chemistry, 1950